Terapia Ranbaxy 3Q Turnover Up 5%, To RON110M

11.05.2013 By Oana Gavrila

Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, registered a growth of around 5% in turnover in the third quarter, to RON110 million (EUR24.7 million), driven by the launch of new products.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
TERAPIA RANBAXY
, TURNOVER
,

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.